logo
Plus   Neg
Share
Email

Sorrento To Explore Its Agents In Combination With ViralClear's Merimepodib Against COVID-19

ViralClear Pharmaceuticals, Inc. (BSGM) and Sorrento Therapeutics, Inc. (SRNE) have entered into an agreement to explore the synergistic potential of small molecules and antibodies combination therapies against COVID-19. ViralClear will contribute its oral antiviral Merimepodib which is currently in a phase 2 trial in combination with remdesivir to treat COVID-19. The agreement will allow for testing of merimepodib with neutralizing antibodies in the Golden Syrian hamster model of COVID-19.

The companies said, pending the outcome of these studies, the results might be presented to the FDA to support the initiation of a human clinical trial of the drug combination.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
After providing free and discounted rides to the polls on Election Day, Lyft is now set to support voters with discounted rides to the polls for the federal runoff races in Louisiana and Georgia. They also provided similar rides during the primary season. The ride-sharing company is continuing its Voting Access Program to provide affordable transportation to voters in need. Discount retailer Dollar General Corp. and supermarket chain Kroger Co. on Thursday reported sharp increases in their quarterly profits on higher sales. While Dollar General's results trounced analysts' estimates, Kroger's earnings beat expectations while revenue fell short. Dollar General's profit for the third quarter surged 57 percent from last year. On January 4, 2021, Discovery plans to launch its new standalone streaming service called Discovery+ which will also offer exclusive streaming access to the BBC's award-winning natural history shows like Planet Earth, Blue Planet, and Frozen Planet. The channel is expected to offer the largest content of real-life entertainment provided by any streaming platform at launch.
RELATED NEWS
Follow RTT